{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:01:02Z","timestamp":1788433262390,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,3,22]],"date-time":"2004-03-22T00:00:00Z","timestamp":1079913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,3,22]],"date-time":"2004-03-22T00:00:00Z","timestamp":1079913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1038\/sj.bmt.1704466","type":"journal-article","created":{"date-parts":[[2004,3,22]],"date-time":"2004-03-22T12:44:27Z","timestamp":1079959467000},"page":"907-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma"],"prefix":"10.1038","volume":"33","author":[{"given":"T","family":"Kuittinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nousiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Halonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mahlam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Jantunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,22]]},"reference":[{"key":"BF1704466_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/sj.bmt.1702995","volume":"27","author":"A Gratwohl","year":"2001","unstructured":"Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A . Blood and marrow transplantation activity in Europe 1999. Special report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2001; 27: 899\u2013916.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR2","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1182\/blood-2002-03-0675","volume":"100","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Horisberger B et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374\u20132386.","journal-title":"Blood"},{"key":"BF1704466_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1365-2141.2001.02926.x","volume":"114","author":"E Vellenga","year":"2001","unstructured":"Vellenga E, van Anthoven M, Croockewit AJ et al. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study. Br J Haematol 2001; 114: 319\u2013326.","journal-title":"Br J Haematol"},{"issue":"Suppl. 2","key":"BF1704466_CR4","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1038\/sj.bmt.1701670","volume":"23","author":"J Glaspy","year":"1999","unstructured":"Glaspy J . Economic consideration in the use of peripheral blood progenitor cells to support high-dose chemotherapy. Bone Marrow Transplant 1999; 23 (Suppl. 2): S21\u2013S27.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR5","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2000.18.16.3063","volume":"18","author":"L Akard","year":"2000","unstructured":"Akard L . Optimum methods to mobilize stem cells. J Clin Oncol 2000; 18: 3063\u20133064.","journal-title":"J Clin Oncol"},{"key":"BF1704466_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bmt.1703837","volume":"31","author":"A Kessinger","year":"2003","unstructured":"Kessinger A, Sharp JG . The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplant 2003; 31: 319\u2013329.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2141.1993.tb08675.x","volume":"85","author":"J Craig","year":"1993","unstructured":"Craig J, Anthony R, Stewart A et al. Peripheral blood stem cell mobilization using high-dose cyclophosphamide and G-CSF in pretreated patients with lymphoma. Br J Haematol 1993; 85: 210\u2013212.","journal-title":"Br J Haematol"},{"key":"BF1704466_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.bmt.1703364","volume":"29","author":"V Pavone","year":"2002","unstructured":"Pavone V, Gaudio F, Guarini A et al. Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma. Bone Marrow Transplant 2002; 29: 285\u2013290.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1200\/JCO.1997.15.2.535","volume":"15","author":"MJ Watts","year":"1997","unstructured":"Watts MJ, Sullivan AM, Jamieson E et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 1997; 15: 535\u2013546.","journal-title":"J Clin Oncol"},{"key":"BF1704466_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.bmt.1703653","volume":"30","author":"P Mollee","year":"2002","unstructured":"Mollee P, Pereira D, Nagy T et al. Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplant 2002; 30: 273\u2013278.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/10428190009113381","volume":"39","author":"MW Sugrue","year":"2000","unstructured":"Sugrue MW, Williams K, Pollack BH et al. Characterization and outcome of \u2018hard to mobilize\u2019 lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2000; 39: 509\u2013519.","journal-title":"Leuk Lymphoma"},{"key":"BF1704466_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1083-8791(00)70021-8","volume":"6","author":"KE Stockerl-Goldstein","year":"2000","unstructured":"Stockerl-Goldstein KE, Reddy SA, Horning SJ et al. Favorable treatment outcome in non-Hodgkin's lymphoma patients with \u2018poor\u2019 mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant 2000; 6: 506\u2013512.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl. 2","key":"BF1704466_CR13","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/sj.bmt.1701671","volume":"23","author":"PJ Stiff","year":"1999","unstructured":"Stiff PJ . Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999; 23 (Suppl. 2): S29\u2013S33.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.thj.6200061","volume":"1","author":"I Micallef","year":"2002","unstructured":"Micallef I, Apostolidis J, Rohatiner A et al. Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J 2002; 1: 367\u2013373.","journal-title":"Hematol J"},{"key":"BF1704466_CR15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al. A revised European\u2013American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361\u20131392.","journal-title":"Blood"},{"key":"BF1704466_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/sj.bmt.1700808","volume":"19","author":"CH Weaver","year":"1997","unstructured":"Weaver CH, Potz J, Redmond J et al. Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content. Bone Marrow Transplant 1997; 19: 1103\u20131110.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR17","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","volume":"13","author":"W Bensinger","year":"1995","unstructured":"Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547\u20132555.","journal-title":"J Clin Oncol"},{"key":"BF1704466_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/sj.bmt.1701267","volume":"21","author":"AR Perry","year":"1998","unstructured":"Perry AR, Watts MJ, Peniket AJ et al. Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy. Bone Marrow Transplant 1998; 21: 1201\u20131205.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/stem.170055","volume":"17","author":"C Tarella","year":"1999","unstructured":"Tarella C, Zallio F, Caracciole D et al. Hemopoietic progenitor cell mobilization and harvest following intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells 1999; 17: 55\u201361.","journal-title":"Stem Cells"},{"key":"BF1704466_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1046\/j.1365-2141.1997.2743091.x","volume":"98","author":"M Drake","year":"1997","unstructured":"Drake M, Ranaghan L, Morris TCM et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745\u2013749.","journal-title":"Br J Haematol"},{"key":"BF1704466_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bmt.1701461","volume":"22","author":"RE Clark","year":"1998","unstructured":"Clark RE, Brammer CG . Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system. Bone Marrow Transplant 1998; 22: 859\u2013863.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/sj.bmt.1704184","volume":"32","author":"E Jantunen","year":"2003","unstructured":"Jantunen E, Kuittinen T, Nousiainen T . Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma? Bone Marrow Transplant 2003; 32: 569\u2013573.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/stem.5530130508","volume":"13","author":"AW Roberts","year":"1995","unstructured":"Roberts AW, DeLuca E, Begley CG et al. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 1995; 13: 512\u2013516.","journal-title":"Stem Cells"},{"key":"BF1704466_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/sj.bmt.1702201","volume":"25","author":"JM Vantelon","year":"2000","unstructured":"Vantelon JM, Koscielny S, Brault P et al. Scoring system for the prediction of successful peripheral blood stem cell (PBPC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice. Bone Marrow Transplant 2000; 25: 495\u2013499.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2141.2003.04483.x","volume":"122","author":"S Fruehauf","year":"2003","unstructured":"Fruehauf S, Seggewiss R . It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement. Br J Haematol 2003; 122: 360\u2013375.","journal-title":"Br J Haematol"},{"key":"BF1704466_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.bmt.1703860","volume":"31","author":"LB To","year":"2003","unstructured":"To LB, Bashford J, Durrant S et al. Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilisation with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplant 2003; 31: 371\u2013378.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704466_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2003-02-0440","volume":"102","author":"RM Lemoli","year":"2003","unstructured":"Lemoli RM, de Vivo A, Damiani D et al. Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood 2003; 102: 1595\u20131600.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704466","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:08:56Z","timestamp":1648076936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,22]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["BF1704466"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704466","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,22]]},"assertion":[{"value":"1 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}